JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Siegall, C. B.
Right arrow Articles by Fell, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Siegall, C. B.
Right arrow Articles by Fell, H. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 270, Number 13, Issue of March 31, 1995 pp. 7625-7630
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
HER4 Expression Correlates with Cytotoxicity Directed by a Heregulin-Toxin Fusion Protein

(Received for publication, December 2, 1994)

Clay B. Siegall Sarah S. Bacus Bruce D. Cohen Gregory D. Plowman Bruce Mixan Dana Chace Dot M. Chin Andy Goetze Janell M. Green Ingegerd Hellström Karl Erik Hellström H. Perry Fell

We have constructed, expressed, and purified a fusion protein, HAR-TX beta2, consisting of heregulin-beta2 fused to a binding-defective form of Pseudomonas exotoxin A, PE40. The fusion protein was found to induce receptor tyrosine phosphorylation in CEM cells transfected with HER4 alone or in combination with HER2 but not in cells transfected with HER2 or HER1 alone. The phosphorylation of receptor tyrosines was both dose-dependent and saturable in amounts similar to those shown to be active for native heregulin. HAR-TX beta2 was specifically cytotoxic toward a variety of carcinoma cell lines in the ng/ml range. However, some tumor cell lines were found to be insensitive to the cytotoxic action of the fusion protein even at >2 µg/ml. Relative amounts of HER4, HER3, and HER2 were determined on seven cell lines sensitive and four cell lines insensitive to HAR-TX beta2. All lines that express HER4 were killed by HAR-TX beta2, while none lacking HER4 were affected. HAR-TX beta2 was able to bind to and signal via tyrosine phosphorylation in cell lines that co-express HER2 and HER3 in the absence of HER4 without inducing cytotoxicity. Thus HAR-TX beta2 may prove to be a useful reagent for the targeting and elimination of HER4-positive tumor cells.




Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
R. Srinivasan, C. E. Gillett, D. M. Barnes, and W. J. Gullick
Nuclear Expression of the c-erbB-4/HER-4 Growth Factor Receptor in Invasive Breast Cancers
Cancer Res., March 1, 2000; 60(6): 1483 - 1487.
[Abstract] [Full Text]


Home page
Protein Eng Des SelHome page
R. Landgraf, D. Fischer, and D. Eisenberg
Analysis of heregulin symmetry by weighted evolutionary tracing
Protein Eng. Des. Sel., November 1, 1999; 12(11): 943 - 951.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. D. Cohen, P. A. Kiener, J. M. Green, L. Foy, H. P. Fell, and K. Zhang
The Relationship between Human Epidermal Growth-like Factor Receptor Expression and Cellular Transformation in NIH3T3 Cells
J. Biol. Chem., November 29, 1996; 271(48): 30897 - 30903.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. D. Cohen, J. M. Green, L. Foy, and H. P. Fell
HER4-mediated Biological and Biochemical Properties in NIH 3T3 Cells
J. Biol. Chem., March 1, 1996; 271(9): 4813 - 4818.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Baulida, M. H. Kraus, M. Alimandi, P. P. Di Fiore, and G. Carpenter
All ErbB Receptors Other Than the Epidermal Growth Factor Receptor Are Endocytosis Impaired
J. Biol. Chem., March 1, 1996; 271(9): 5251 - 5257.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
O Bermingham-McDonogh, K. McCabe, and T. Reh
Effects of GGF/neuregulins on neuronal survival and neurite outgrowth correlate with erbB2/neu expression in developing rat retina
Development, January 5, 1996; 122(5): 1427 - 1438.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.